Literature DB >> 25339666

Akt-dependent enhanced migratory capacity of Th17 cells from children with lupus nephritis.

Sudhir Kshirsagar1, Magdalena Riedl1, Heiko Billing2, Burkhard Tönshoff3, Shanmugapriya Thangavadivel4, Christian Steuber5, Hagen Staude6, Gottfried Wechselberger7, Monika Edelbauer8.   

Abstract

Th17 cells infiltrate the kidneys of patients with lupus nephritis (LN) and are critical for the pathogenesis of this disease. In this study, we show that enhanced activity of Stat3 in CD4(+)CD45RA(-)Foxp3(-) and Foxp3(low) effector T cells from children with LN correlates with increased frequencies of IL-17-producing cells within these T cell populations. The levels of retinoic acid-related orphan receptor c and IL-17 mRNA are significantly higher in PBMCs from children with LN than in those from controls. Mammalian target of rapamycin inhibition by rapamycin reduces both Stat3 activation in effector T cells and the frequency of IL-17-producing T cells in lupus patients. Complement factor C5a slightly increases the expression of IL-17 and induces activation of Akt in anti-CD3-activated lupus effector T cells. Th17 cells from children with LN exhibit high Akt activity and enhanced migratory capacity. Inhibition of the Akt signaling pathway significantly decreases Th17 cell migration. These findings indicate that the Akt signaling pathway plays a significant role in the migratory activity of Th17 cells from children with LN and suggest that therapeutic modulation of the Akt activity may inhibit Th17 cell trafficking to sites of inflammation and thus suppress chronic inflammatory processes in children with LN.
Copyright © 2014 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25339666     DOI: 10.4049/jimmunol.1400044

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

Review 1.  T cells in Systemic Lupus Erythematosus.

Authors:  Abel Suárez-Fueyo; Sean J Bradley; George C Tsokos
Journal:  Curr Opin Immunol       Date:  2016-09-13       Impact factor: 7.486

2.  Activation of TGF-β-induced non-Smad signaling pathways during Th17 differentiation.

Authors:  Maruf Hasan; Bernhard Neumann; Steffen Haupeltshofer; Sarah Stahlke; Massimo Claudio Fantini; Klemens Angstwurm; Ulrich Bogdahn; Ingo Kleiter
Journal:  Immunol Cell Biol       Date:  2015-03-31       Impact factor: 5.126

Review 3.  T cells and autoimmune kidney disease.

Authors:  Abel Suárez-Fueyo; Sean J Bradley; David Klatzmann; George C Tsokos
Journal:  Nat Rev Nephrol       Date:  2017-03-13       Impact factor: 28.314

4.  IL-17A suppresses and curcumin up-regulates Akt expression upon bleomycin exposure.

Authors:  Mahesh Manjunath Gouda; Ashwini Prabhu; Yashodhar Prabhakar Bhandary
Journal:  Mol Biol Rep       Date:  2018-05-28       Impact factor: 2.316

Review 5.  Activation of the Mechanistic Target of Rapamycin in SLE: Explosion of Evidence in the Last Five Years.

Authors:  Zachary Oaks; Thomas Winans; Nick Huang; Katalin Banki; Andras Perl
Journal:  Curr Rheumatol Rep       Date:  2016-12       Impact factor: 4.592

Review 6.  Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases.

Authors:  Andras Perl
Journal:  Nat Rev Rheumatol       Date:  2015-12-24       Impact factor: 20.543

7.  C5a alters blood-brain barrier integrity in a human in vitro model of systemic lupus erythematosus.

Authors:  Supriya D Mahajan; Neil U Parikh; Trent M Woodruff; James N Jarvis; Molly Lopez; Teresa Hennon; Patrick Cunningham; Richard J Quigg; Stanley A Schwartz; Jessy J Alexander
Journal:  Immunology       Date:  2015-07-15       Impact factor: 7.397

8.  Low dose of IL-2 combined with rapamycin restores and maintains the long-term balance of Th17/Treg cells in refractory SLE patients.

Authors:  Chunmiao Zhao; Yanfang Chu; Zhaoyun Liang; Bingying Zhang; Xuxia Wang; Xiaona Jing; Meihua Hao; Yiqi Wang; Jia An; Xingzhe Zhang; Liguang Sun; Junwei Chen
Journal:  BMC Immunol       Date:  2019-09-04       Impact factor: 3.615

Review 9.  Aberrant T Cell Signaling and Subsets in Systemic Lupus Erythematosus.

Authors:  Takayuki Katsuyama; George C Tsokos; Vaishali R Moulton
Journal:  Front Immunol       Date:  2018-05-17       Impact factor: 7.561

10.  LRCH1 suppresses migration of CD4+ T cells and refers to disease activity in ulcerative colitis.

Authors:  Yibo Wang; Hairong Zhang; Heng He; Kuankuan Ai; Wei Yu; Xiao Xiao; Yufen Qin; Lingming Zhang; Huabao Xiong; Guangxi Zhou
Journal:  Int J Med Sci       Date:  2020-02-17       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.